查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球远端患者监护市场中的人工智慧按组件、适应症、最终用户和地区划分 - 预测至 2030 年
市场调查报告书
商品编码
1680999

全球远端患者监护市场中的人工智慧按组件、适应症、最终用户和地区划分 - 预测至 2030 年

AI in Remote Patient Monitoring Market by Component, Indication, End User, Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 324 Pages | 订单完成后即时交付

价格

远端患者监护人工智慧的市场规模预计将从 2024 年的 19.677 亿美元增长到 2030 年的 84.385 亿美元，预测期内的复合年增长率为 27.5%。

感染疾病感染疾病？这些感染疾病与医院内的严重健康併发症和死亡有关，因此远端病人监控解决方案对于预防和管理风险是必不可少的。此外，心血管疾病、肥胖症和糖尿病等慢性病的发生率不断上升，推动了对有效的远端监控技术的需求。美国的医疗成本正在上升，近一半的成年人无法负担处方药或看医生的费用。根据美国疾病管制与预防中心统计，大约每 31 名住院患者中就有 1 名会罹患至少一种医疗相关感染疾病。例如，匹兹堡大学医学中心报告称，RPM 设备将医院再入院率降低了 76%。

研究范围
调查年份 2022-2030
基准年 2023
预测期 2024-2030
考虑单位 金额（百万美元）
部分 按成分、按适应症、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东和非洲

由于支援人工智慧的生物感测器、智慧型手錶和医疗穿戴式装置的接受度不断提高，穿戴式装置预计将在 2023 年成为远端患者监护市场中成长最快的人工智慧领域。这些设备基于机器学习、深度学习和生命体征的持续监测，以便及早发现潜在的健康问题并提供预测性见解。穿戴式装置的其他发展，包括支援人工智慧的心电图监控、血糖监测和远端医疗，透过提高病人参与和慢性病管理，进一步支持了这一成长。例如，2024年8月，Masimo的W1医疗手錶整合到Masimo SafetyNet远端监控系统中，获得FDA 510(k)批准，可进行即时远端健康监控。

远端患者监护中的人工智慧市场分为五大地理区域：北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。北美地区在远端患者监护市场占据主导地位，原因如下：医疗技术的采用率明显较高、医疗保健基础设施强大而完善，以及为支持这些进步而不断增长的医疗保健支出。此外，患者患慢性病的趋势和对家庭医疗保健解决方案日益增长的需求也可能推动该地区市场的成长。截至2023年，已有超过500种医疗AI设备经过美国食品药物管理局（FDA）的评估和核准，其中包括RPM相关的医疗设备。

本报告研究了全球远端患者监护人工智慧市场，并对市场格局进行了深入分析，包括按组件、适应症、最终用户、地理位置和公司概况进行细分。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章 市场概况

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/干扰
  • 产业趋势
  • 生态系分析
  • 价值链分析
  • 技术分析
  • 资费和监管分析
  • 贸易分析
  • 定价分析
  • 波特五力分析
  • 主要相关人员和采购标准
  • 专利分析
  • 未满足的需求和最终用户的期望
  • 2025-2026 年重要会议与活动
  • 案例研究分析
  • 投资金筹措场景
  • 经营模式分析
  • 还款情境分析

第六章远端患者监护市场中的人工智慧（按组件）

  • 介绍
  • 装置
  • 软体
  • 服务

第 7 章远端患者监护市场中的人工智慧（按适应症分类）

  • 介绍
  • 瘤
  • 心臟病
  • 神经系统疾病
  • 糖尿病
  • 睡眠障碍
  • 呼吸系统疾病
  • 健康促进
  • 精神疾病
  • 其他的

第 8 章远端患者监护市场中的人工智慧（按最终用户划分）

  • 介绍
  • 医疗机构
  • 医疗保健付款人
  • 病人
  • 製药和生物技术公司
  • 医疗科技公司
  • 其他的

第九章远端患者监护市场中的人工智慧（按地区）

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 亚太宏观经济展望
    • 中国
    • 日本
    • 印度
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 中东和非洲宏观经济展望
    • 海湾合作委员会国家
    • 其他的

第十章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 2019 至 2023 年收益分析
  • 2023 年市场占有率分析
  • 公司估值矩阵：主要参与企业，2023 年
  • 公司估值矩阵：Start-Ups/中小企业，2023 年
  • 估值及财务指标
  • 品牌/软体比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • MEDTRONIC
    • KONINKLIJKE PHILIPS NV
    • GE HEALTHCARE
    • BOSTON SCIENTIFIC CORPORATION
    • OMRON HEALTHCARE, INC.
    • RESMED, INC.
    • NIHON KOHDEN CORPORATION
    • F. HOFFMANN-LA ROCHE LTD.（ROCHE DIAGNOSTICS）
    • IRHYTHM INC.
    • BEIJING CHOICE ELECTRONIC TECH CO., LTD.
    • BIOTRONIK
    • ALIVECOR, INC.
    • MASIMO
    • DEXCOM, INC.
    • BIOBEAT
    • TYTOCARE LTD.
    • ZETO INC.
    • GLOOKO, INC.
    • WELLDOC, INC.
    • TURTLE SHELL TECHNOLOGIES PVT. LTD.（DOZEE）
  • 其他公司
    • BIOINTELLISENSE, INC.
    • BLUE SPARK TECHNOLOGIES, INC.
    • ACCURKARDIA, INC.
    • AION BIOSYSTEMS, INC.
    • BROOK INC.

第十二章 附录

Product Code: HIT 9321

The AI in remote patient monitoring market is projected to reach USD 8,438.5 million by 2030 from USD 1,967.7 million in 2024, at a high CAGR of 27.5% during the forecast period. Reason for growth in the AI in remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. According to US CDC about 1 in 31 hospital patients has at least one healthcare-associated infection. For instance, the University of Pittsburgh Medical Center reported that RPM devices reduced hospital readmissions by 76%.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredValue (USD Million)
SegmentsComponent, Indication, and End-user and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

"Wearable devices is the fastest growing segment in the AI in remote patient monitoring market by devices in 2023"

Wearable devices is expected to be the fastest-growing segment in the AI in remote patient monitoring market during 2023, due to the increasing acceptance of AI-enabled biosensors, smartwatches, and wearables for medical use. These devices are based on machine learning, deep learning, and continuous monitoring of vital signs, early detecting potential health issues, and supplying predictive insights. Other developments in AI-enabled ECG monitoring, glucose monitoring, and telehealth-enabling wearables are further supporting growth by increasing patient engagement and chronic disease management. For instance, in August 2024, Masimo's W1 Medical Watch received FDA 510(k) clearance to be incorporated into the Masimo SafetyNet Telemonitoring System for remote monitoring of health in real-time.

"North America dominated the remote patient monitoring market in 2023."

The AI in remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region's market. As of 2023, over 500 medical AI devices have undergone U.S. Food and Drug Administration (FDA) evaluation and received approval including RPM related medical devices.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
  • By Designation - C-level: 35%, Director-level: 40%, and Others: 25%
  • By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthcare, Inc. (Japan), GE HealthCare (US), Medtronic (Ireland), AliveCor, Inc. (US), NIHON KOHDEN CORPORATION (Japan), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), Beijing Choice Electronic Tech Co. Ltd (US), Biobeat (Israel), Biotronik (Germany), and AccurKardia, Inc. (US) are some of the key players in the AI in remote patient monitoring market.

  • The study includes an in-depth competitive analysis of these key players in the AI in remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the AI in remote patient monitoring market by component (devices [wearable devices, implantable devices, handheld & portable devices, stationary devices]), software and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and other indications (obstetrics, immunology, infectious diseases, ophthalmology, and others). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the AI in remote patient monitoring market. Competitive analysis of upcoming startups in the AI in remote patient monitoring market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the AI in remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (growing telehealth and remote patient monitoring markets, rising prevalence of chronic diseases, growing adoption of mhealth apps, increased government support and favorable reimbursement policies, growing awareness about lifestyle management and home healthcare) restraints (regulatory variations across regions, shortage of skilled professionals to operate AI based tools, and data security concerns) opportunities (growing in the demand for personalized medicine, increase in the partnership and collaboration among healthcare providers and AI based companies, growing opportunities in emerging nations, hospital-at-home, and rising investment in AI based RPM solutions) challenges (issues related to accuracy due to scarcity of high quality healthcare data, reluctance among healthcare professionals to adopt AI in remote patient monitoring, and lack of interoperability)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in remote patient monitoring market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the AI in remote patient monitoring market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in remote patient monitoring market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Healthare, Inc. (Japan), GE HealthCare (US), Boston Scientific Corporation (US), F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland), NIHON KOHDEN CORPORATION (Japan), and Biotronik (Germany); among others in the AI in remote patient monitoring market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key sources of secondary data
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key sources of primary data
      • 2.1.2.2 Objectives of primary research
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Key insights from primary experts
      • 2.1.2.5 Breakdown of primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 SUPPLY-SIDE ANALYSIS
    • 2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
    • 2.2.3 TOP-DOWN APPROACH
    • 2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.3 DATA TRIANGULATION
  • 2.4 STUDY ASSUMPTIONS
    • 2.4.1 MARKET SIZING ASSUMPTIONS
    • 2.4.2 MARKET GROWTH ASSUMPTIONS
  • 2.5 RISK ANALYSIS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 AI IN REMOTE PATIENT MONITORING MARKET OVERVIEW
  • 4.2 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER AND REGION, 2023
  • 4.3 AI IN REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4 AI IN REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Expanding telehealth and remote patient monitoring markets
      • 5.2.1.2 Increasing prevalence of chronic diseases
      • 5.2.1.3 Focus on development and adoption of mHealth applications
      • 5.2.1.4 Increased government support and favorable reimbursement policies
      • 5.2.1.5 Growing awareness about lifestyle management and home healthcare
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory variations across regions
      • 5.2.2.2 Shortage of skilled professionals to operate AI-based remote patient monitoring tools
      • 5.2.2.3 Data security concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for personalized medicines and care plans
      • 5.2.3.2 Increase in partnerships and collaborations among healthcare providers and AI-based companies
      • 5.2.3.3 Growth opportunities in emerging economies
      • 5.2.3.4 Rising investment in AI-based remote patient monitoring solutions
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Scarcity of high-quality healthcare data and privacy concerns
      • 5.2.4.2 Reluctance among healthcare professionals to adopt AI in remote patient monitoring devices
      • 5.2.4.3 Lack of interoperability
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
    • 5.4.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGIES
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 ROLE IN ECOSYSTEM
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Wearable devices and sensors
      • 5.7.1.2 AI and ML
      • 5.7.1.3 Predictive analytics
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 mHealth applications
      • 5.7.2.2 Cloud computing
      • 5.7.2.3 Digital health platforms
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Point-of-care diagnostics
      • 5.7.3.2 Smart home health devices
  • 5.8 TARIFF & REGULATORY ANALYSIS
    • 5.8.1 TARIFF ANALYSIS
      • 5.8.1.1 Tariff data for HS code 9018
      • 5.8.1.2 Tariff data for HS code 9021
      • 5.8.1.3 Tariff data for HS code 9022
    • 5.8.2 REGULATORY FRAMEWORK
      • 5.8.2.1 North America
      • 5.8.2.2 Europe
      • 5.8.2.3 Asia Pacific
      • 5.8.2.4 Middle East & Africa
      • 5.8.2.5 Latin America
    • 5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099
      • 5.9.1.1 Import data for HSN code 90189099
      • 5.9.1.2 Export data for HSN code 90189099
    • 5.9.2 TRADE ANALYSIS FOR HSN CODE 9021
      • 5.9.2.1 Import data for HSN code 9021
      • 5.9.2.2 Export data for HSN code 9021
    • 5.9.3 TRADE ANALYSIS FOR HSN CODE 9022
      • 5.9.3.1 Import data for HSN code 9022
      • 5.9.3.2 Export data for HSN code 9022
  • 5.10 PRICING ANALYSIS
    • 5.10.1 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
    • 5.10.2 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.11.2 BARGAINING POWER OF BUYERS
    • 5.11.3 THREAT OF SUBSTITUTES
    • 5.11.4 THREAT OF NEW ENTRANTS
    • 5.11.5 BARGAINING POWER OF SUPPLIERS
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.12.2 KEY BUYING CRITERIA
  • 5.13 PATENT ANALYSIS
    • 5.13.1 PATENT PUBLICATION TRENDS
    • 5.13.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
    • 5.13.3 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET
    • 5.13.4 LIST OF KEY PATENTS/PATENT APPLICATIONS
  • 5.14 UNMET NEEDS & END-USER EXPECTATIONS
    • 5.14.1 UNMET NEEDS
    • 5.14.2 END-USER EXPECTATIONS
  • 5.15 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
    • 5.16.2 ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
    • 5.16.3 ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 BUSINESS MODEL ANALYSIS
    • 5.18.1 SUBSCRIPTION-BASED MODELS
    • 5.18.2 PLATFORM-AS-A-SERVICE MODELS
    • 5.18.3 SERVICE-BASED MODELS
    • 5.18.4 FREEMIUM MODELS
    • 5.18.5 COLLABORATIVE ECOSYSTEM AND PARTNERSHIP MODELS
  • 5.19 REIMBURSEMENT SCENARIO ANALYSIS

6 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    • 6.2.1 WEARABLE DEVICES
      • 6.2.1.1 Rising adoption of consumer health technologies and growing trend toward preventive healthcare to drive segment
    • 6.2.2 IMPLANTABLE DEVICES
      • 6.2.2.1 Development of wireless communication technologies and advancements in medical devices to spur market adoption
    • 6.2.3 HANDHELD & PORTABLE DEVICES
      • 6.2.3.1 Rising consumer preference for home healthcare and self-monitoring to aid market growth
    • 6.2.4 STATIONARY DEVICES
      • 6.2.4.1 Reduced hospitalizations and improved patient outcomes through timely alerts to aid market growth
  • 6.3 SOFTWARE
    • 6.3.1 EFFECTIVE TRANSFORMATION OF RAW DATA TO PERSONALIZED INSIGHTS FOR PATIENTS TO AUGMENT MARKET GROWTH
  • 6.4 SERVICES
    • 6.4.1 INCREASING NEED FOR VALUE-BASED SPECIALIZED SERVICES TO BOOST MARKET GROWTH

7 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION

  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    • 7.2.1 NEED FOR IMPROVED SYMPTOM MONITORING AND PERSONALIZED TREATMENT PLANS TO DRIVE MARKET
  • 7.3 CARDIOLOGY
    • 7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET GROWTH
  • 7.4 NEUROLOGY
    • 7.4.1 GROWING ADOPTION OF TELEMEDICINE AND RISING NEED FOR CONTINUOUS MONITORING TO AID MARKET GROWTH
  • 7.5 DIABETES
    • 7.5.1 HIGH ADOPTION OF AI-POWERED DEVICES FOR EFFECTIVE DIABETES MANAGEMENT TO PROPEL MARKET GROWTH
  • 7.6 SLEEP DISORDERS
    • 7.6.1 AI-POWERED REMOTE PATIENT MONITORING DEVICES TO ENSURE EFFECTIVE SLEEP APNEA MANAGEMENT
  • 7.7 RESPIRATORY DISEASES
    • 7.7.1 GROWING BURDEN OF COPD AND ASTHMA IN LOW- AND MIDDLE-INCOME COUNTRIES TO SUPPORT MARKET GROWTH
  • 7.8 WELLNESS IMPROVEMENT
    • 7.8.1 RISING PREVALENCE OF OBESITY AND LIFESTYLE DISEASES TO AUGMENT MARKET GROWTH
  • 7.9 MENTAL HEALTH DISORDERS
    • 7.9.1 AI-BASED REMOTE PATIENT MONITORING TO IMPROVE ACCESS TO MENTAL HEALTH SUPPORT AND REDUCE STIGMA OF IN-PERSON THERAPY
  • 7.10 OTHER INDICATIONS

8 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HEALTHCARE PROVIDERS
    • 8.2.1 HOSPITALS
      • 8.2.1.1 Rising demand for high-quality care and increasing incidence of chronic diseases to drive market
    • 8.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
      • 8.2.2.1 AI-driven remote patient monitoring devices to enhance postoperative care, patient safety, and recovery outcomes
    • 8.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
      • 8.2.3.1 Need for prolonged treatment for chronic diseases and high cost of hospital stays to fuel uptake
    • 8.2.4 HOME HEALTHCARE FACILITIES
      • 8.2.4.1 Increased preference for at-home treatment options to drive market
    • 8.2.5 OTHER HEALTHCARE PROVIDERS
  • 8.3 HEALTHCARE PAYERS
    • 8.3.1 FAVORABLE REIMBURSEMENT SCENARIO FOR REMOTE PATIENT MONITORING SERVICES TO AUGMENT MARKET GROWTH
  • 8.4 PATIENTS
    • 8.4.1 ADVANCEMENTS IN WEARABLE DEVICES AND PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH
  • 8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.5.1 AI-BASED REMOTE PATIENT MONITORING SOLUTIONS TO ASSIST PHARMA COMPANIES EXPAND MARKET PRESENCE
  • 8.6 MEDTECH COMPANIES
    • 8.6.1 RISING DEMAND FOR ADVANCED TECHNOLOGIES FOR REMOTE DISEASE DIAGNOSIS AND TREATMENT TO FAVOR MARKET GROWTH
  • 8.7 OTHER END USERS

9 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 US to dominate North American market during study period
    • 9.2.3 CANADA
      • 9.2.3.1 Need to curtail healthcare costs and high penetration of smartphones and tablets to drive market
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 High healthcare expenditure and increased preference for home monitoring to propel market growth
    • 9.3.3 UK
      • 9.3.3.1 Favorable government initiatives and high demand for advanced healthcare solutions to aid market growth
    • 9.3.4 FRANCE
      • 9.3.4.1 Increased adoption of connected medical devices to fuel market growth
    • 9.3.5 ITALY
      • 9.3.5.1 Increased government health expenditure and high geriatric population to boost market growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Need to reduce healthcare costs and improve treatment quality to drive adoption of AI-based remote patient monitoring devices
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Strong internet access and high smartphone adoption to augment market growth
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising geriatric population and increasing government health expenditure to aid market growth
    • 9.4.4 INDIA
      • 9.4.4.1 Need to bridge gap between rural patients and urban doctors to propel market growth
    • 9.4.5 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Favorable government initiatives and increased health expenditure to favor market growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Technological advancements and favorable legal policies for digital health technologies to drive market
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Favorable government and non-government initiatives and increased investment in healthcare infrastructure to drive market
    • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS FOR AI IN REMOTE PATIENT MONITORING MARKET
  • 10.3 REVENUE ANALYSIS, 2019-2023
  • 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 10.5.5.1 Company footprint
      • 10.5.5.2 Region footprint
      • 10.5.5.3 Component footprint
      • 10.5.5.4 Indication footprint
      • 10.5.5.5 End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 10.6.5.1 Detailed list of key startups/SMEs
      • 10.6.5.2 Competitive benchmarking of key emerging players/startups
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    • 10.7.1 FINANCIAL METRICS
    • 10.7.2 COMPANY VALUATION
  • 10.8 BRAND/SOFTWARE COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS
    • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 MEDTRONIC
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services/Solutions offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product approvals
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 KONINKLIJKE PHILIPS N.V.
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services/Solutions offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Product launches & approvals
        • 11.1.2.3.2 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 GE HEALTHCARE
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services/Solutions offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 BOSTON SCIENTIFIC CORPORATION
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services/Solutions offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Product launches
        • 11.1.4.3.2 Deals
        • 11.1.4.3.3 Expansions
        • 11.1.4.3.4 Other developments
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 OMRON HEALTHCARE, INC.
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services/Solutions offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Product approvals & enhancements
        • 11.1.5.3.2 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses & competitive threats
    • 11.1.6 RESMED, INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services/Solutions offered
      • 11.1.6.3 Recent developments
        • 11.1.6.3.1 Product launches & enhancements
        • 11.1.6.3.2 Deals
        • 11.1.6.3.3 Expansions
        • 11.1.6.3.4 Other developments
    • 11.1.7 NIHON KOHDEN CORPORATION
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services/Solutions offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Product launches & approvals
        • 11.1.7.3.2 Deals
        • 11.1.7.3.3 Other developments
    • 11.1.8 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS)
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services/Solutions offered
      • 11.1.8.3 Recent developments
        • 11.1.8.3.1 Product launches & approvals
        • 11.1.8.3.2 Deals
    • 11.1.9 IRHYTHM INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services/Solutions offered
      • 11.1.9.3 Recent developments
        • 11.1.9.3.1 Product launches & approvals
        • 11.1.9.3.2 Deals
    • 11.1.10 BEIJING CHOICE ELECTRONIC TECH CO., LTD.
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services/Solutions offered
    • 11.1.11 BIOTRONIK
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services/Solutions offered
      • 11.1.11.3 Recent developments
        • 11.1.11.3.1 Product launches & approvals
        • 11.1.11.3.2 Deals
    • 11.1.12 ALIVECOR, INC.
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services/Solutions offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Product launches & approvals
        • 11.1.12.3.2 Deals
        • 11.1.12.3.3 Other developments
    • 11.1.13 MASIMO
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services/Solutions offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Product approvals & enhancements
      • 11.1.13.4 Recent developments
        • 11.1.13.4.1 Deals
    • 11.1.14 DEXCOM, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Services/Solutions offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Product launches & approvals
        • 11.1.14.3.2 Deals
    • 11.1.15 BIOBEAT
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Services/Solutions offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Product launches & approvals
        • 11.1.15.3.2 Deals
    • 11.1.16 TYTOCARE LTD.
      • 11.1.16.1 Business overview
      • 11.1.16.2 Products/Services/Solutions offered
      • 11.1.16.3 Recent developments
        • 11.1.16.3.1 Product enhancements
        • 11.1.16.3.2 Deals
        • 11.1.16.3.3 Other developments
    • 11.1.17 ZETO INC.
      • 11.1.17.1 Business overview
      • 11.1.17.2 Products/Services/Solutions offered
    • 11.1.18 GLOOKO, INC.
      • 11.1.18.1 Business overview
      • 11.1.18.2 Products/Services/Solutions offered
      • 11.1.18.3 Recent developments
        • 11.1.18.3.1 Product launches & enhancements
        • 11.1.18.3.2 Deals
        • 11.1.18.3.3 Other developments
    • 11.1.19 WELLDOC, INC.
      • 11.1.19.1 Business overview
      • 11.1.19.2 Products/Services/Solutions offered
      • 11.1.19.3 Recent developments
        • 11.1.19.3.1 Product approvals & enhancements
        • 11.1.19.3.2 Deals
    • 11.1.20 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE)
      • 11.1.20.1 Business overview
      • 11.1.20.2 Products/Services/Solutions offered
      • 11.1.20.3 Recent developments
        • 11.1.20.3.1 Product approvals
        • 11.1.20.3.2 Other developments
  • 11.2 OTHER PLAYERS
    • 11.2.1 BIOINTELLISENSE, INC.
    • 11.2.2 BLUE SPARK TECHNOLOGIES, INC.
    • 11.2.3 ACCURKARDIA, INC.
    • 11.2.4 AION BIOSYSTEMS, INC.
    • 11.2.5 BROOK INC.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 AI IN REMOTE PATIENT MONITORING MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 AI IN REMOTE PATIENT MONITORING MARKET: FACTOR ANALYSIS
  • TABLE 4 AI IN REMOTE PATIENT MONITORING MARKET: MARKET SIZING ASSUMPTIONS
  • TABLE 5 AI IN REMOTE PATIENT MONITORING MARKET: RISK ASSESSMENT
  • TABLE 6 AI IN REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 7 RECENT DEVELOPMENTS IN AI-BASED SOLUTIONS FOR REMOTE PATIENT MONITORING, JANUARY 2022-DECEMBER 2024
  • TABLE 8 AI IN REMOTE PATIENT MONITORING MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9018
  • TABLE 10 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9021
  • TABLE 11 AI IN REMOTE PATIENT MONITORING MARKET: TARIFF DATA FOR HS CODE 9022
  • TABLE 12 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 13 REGULATORY SCENARIO OF EUROPE
  • TABLE 14 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 15 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 16 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 28 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYER, 2023
  • TABLE 29 INDICATIVE PRICING FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY REGION, 2023
  • TABLE 30 AI IN REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES
  • TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS
  • TABLE 34 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 35 AI IN REMOTE PATIENT MONITORING MARKET: UNMET NEEDS
  • TABLE 36 AI IN REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS
  • TABLE 37 AI IN REMOTE PATIENT MONITORING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 38 CASE STUDY 1: ADOPTION OF MEDTRONIC LINQ II WITH ACCURHYTHM AI FOR REMOTE PATIENT MONITORING
  • TABLE 39 CASE STUDY 2: ADOPTION OF ZETO EEG SOLUTIONS FOR NEUROLOGY AND EPILEPSY DIAGNOSIS
  • TABLE 40 CASE STUDY 2: ADOPTION OF DOZEE AI-POWERED BALLISTOCARDIOGRAPHY TECHNOLOGY
  • TABLE 41 CPT CODES AND REIMBURSEMENT ANALYSIS FOR AI-BASED REMOTE PATIENT MONITORING DEVICES IN US
  • TABLE 42 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 43 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 44 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 45 AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (THOUSAND UNITS)
  • TABLE 46 AI IN REMOTE PATIENT MONITORING WEARABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 47 AI IN REMOTE PATIENT MONITORING IMPLANTABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 48 AI IN REMOTE PATIENT MONITORING HANDHELD & PORTABLE DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 49 AI IN REMOTE PATIENT MONITORING STATIONARY DEVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 50 AI IN REMOTE PATIENT MONITORING SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 51 AI IN REMOTE PATIENT MONITORING SERVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 52 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 53 AI IN REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 54 AI IN REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 55 AI IN REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 56 AI IN REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 57 AI IN REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 58 AI IN REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 59 AI IN REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 60 AI IN REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 61 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 62 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 63 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 64 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 65 AI IN REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 66 AI IN REMOTE PATIENT MONITORING MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 67 AI IN REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 68 AI IN REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE FACILITIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 69 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 70 AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 71 AI IN REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 72 AI IN REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 73 AI IN REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 74 AI IN REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 75 AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 80 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 82 US: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 83 US: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 84 US: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 85 US: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 86 US: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 87 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 88 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 89 CANADA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 90 CANADA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 91 CANADA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 92 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 93 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 94 EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 95 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 96 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 97 EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 98 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 99 GERMANY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 100 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 101 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 102 GERMANY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 103 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 104 UK: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 105 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 106 UK: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 107 UK: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 108 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 109 FRANCE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 110 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 111 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 112 FRANCE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 113 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 114 ITALY: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 115 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 116 ITALY: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 117 ITALY: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 118 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 119 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 120 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 121 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 122 SPAIN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 124 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 125 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 126 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 127 REST OF EUROPE: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 130 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 134 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 135 CHINA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 136 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 137 CHINA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 138 CHINA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 139 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 140 JAPAN: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 141 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 142 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 143 JAPAN: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 144 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 145 INDIA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 146 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 147 INDIA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 148 INDIA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 150 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 151 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 152 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 153 REST OF ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 157 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 158 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 159 LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 160 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 161 BRAZIL: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 162 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 163 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 164 BRAZIL: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 165 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 166 MEXICO: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 167 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 168 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 169 MEXICO: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 171 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 172 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 173 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 174 REST OF LATIN AMERICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY REGION, 2022-2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 184 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 185 GCC COUNTRIES: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 186 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
  • TABLE 187 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 188 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022-2030 (USD MILLION)
  • TABLE 189 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 190 REST OF MIDDLE EAST & AFRICA: AI IN REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
  • TABLE 191 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021-JANUARY 2025
  • TABLE 192 AI IN REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION
  • TABLE 193 AI IN REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT
  • TABLE 194 AI IN REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT
  • TABLE 195 AI IN REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT
  • TABLE 196 AI IN REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
  • TABLE 197 AI IN REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 198 AI IN REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 199 AI IN REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 200 AI IN REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 201 AI IN REMOTE PATIENT MONITORING MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 202 AI IN REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 203 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 204 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 205 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 206 MEDTRONIC: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 207 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 208 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 209 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 210 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 211 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 212 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 213 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 214 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 215 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 216 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
  • TABLE 217 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 218 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 219 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 220 OMRON HEALTHCARE, INC.: COMPANY OVERVIEW
  • TABLE 221 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 222 OMRON HEALTHCARE, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 223 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 224 RESMED, INC.: COMPANY OVERVIEW
  • TABLE 225 RESMED, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 226 RESMED, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 227 RESMED, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 228 RESMED, INC.: EXPANSIONS, JANUARY 2021-JANUARY 2025
  • TABLE 229 RESMED, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 230 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 231 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 232 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 233 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 234 NIHON KOHDEN CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 235 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY OVERVIEW
  • TABLE 236 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 237 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 238 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 239 IRHYTHM INC.: COMPANY OVERVIEW
  • TABLE 240 IRHYTHM INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 241 IRHYTHM INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 242 IRHYTHM INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 243 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 244 BEIJING CHOICE ELECTRONIC TECH CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 245 BIOTRONIK: COMPANY OVERVIEW
  • TABLE 246 BIOTRONIK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 247 BIOTRONIK: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 248 BIOTRONIK: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 249 ALIVECOR, INC.: COMPANY OVERVIEW
  • TABLE 250 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 251 ALIVECOR, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 252 ALIVECOR, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 253 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 254 MASIMO: COMPANY OVERVIEW
  • TABLE 255 MASIMO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 256 MASIMO: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 257 MASIMO: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 258 DEXCOM, INC.: COMPANY OVERVIEW
  • TABLE 259 DEXCOM, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 260 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 261 DEXCOM, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 262 BIOBEAT: COMPANY OVERVIEW
  • TABLE 263 BIOBEAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 264 BIOBEAT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 265 BIOBEAT: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 266 TYTOCARE LTD.: COMPANY OVERVIEW
  • TABLE 267 TYTOCARE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 268 TYTOCARE LTD.: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 269 TYTOCARE LTD.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 270 TYTOCARE LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 271 ZETO INC.: COMPANY OVERVIEW
  • TABLE 272 ZETO INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 273 GLOOKO, INC.: COMPANY OVERVIEW
  • TABLE 274 GLOOKO, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 275 GLOOKO, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 276 GLOOKO, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 277 GLOOKO, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 278 WELLDOC, INC.: COMPANY OVERVIEW
  • TABLE 279 WELLDOC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 280 WELLDOC, INC.: PRODUCT APPROVALS & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 281 WELLDOC, INC.: DEALS, JANUARY 2021-JANUARY 2025
  • TABLE 282 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): COMPANY OVERVIEW
  • TABLE 283 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCTS/SERVICES/ SOLUTIONS OFFERED
  • TABLE 284 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
  • TABLE 285 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE): OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
  • TABLE 286 BIOINTELLISENSE, INC.: COMPANY OVERVIEW
  • TABLE 287 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 288 ACCURKARDIA, INC.: COMPANY OVERVIEW
  • TABLE 289 AION BIOSYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 290 BROOK INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 AI IN REMOTE PATIENT MONITORING MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
  • FIGURE 2 AI IN REMOTE PATIENT MONITORING MARKET: YEARS CONSIDERED
  • FIGURE 3 AI IN REMOTE PATIENT MONITORING MARKET: RESEARCH DESIGN
  • FIGURE 4 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 AI IN REMOTE PATIENT MONITORING MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 AI IN REMOTE PATIENT MONITORING MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 AI IN REMOTE PATIENT MONITORING MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY SOURCES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 AI IN REMOTE PATIENT MONITORING MARKET: SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 11 AI IN REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH FOR OMRON HEALTHCARE, INC. (2023)
  • FIGURE 12 BOTTOM-UP APPROACH: END-USER SPENDING ON AI-BASED REMOTE PATIENT MONITORING SOLUTIONS
  • FIGURE 13 AI IN REMOTE PATIENT MONITORING MARKET: TOP-DOWN APPROACH
  • FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
  • FIGURE 15 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 16 AI IN REMOTE PATIENT MONITORING MARKET: DATA TRIANGULATION
  • FIGURE 17 AI IN REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 AI IN REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 AI IN REMOTE PATIENT MONITORING MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 20 AI IN REMOTE PATIENT MONITORING MARKET: REGIONAL SNAPSHOT
  • FIGURE 21 IMPROVED MEDICAL INFRASTRUCTURE AND COST BENEFITS OF REMOTE HEALTH MONITORING TO DRIVE MARKET
  • FIGURE 22 US AND HEALTHCARE PROVIDERS TO COMMAND LARGEST NORTH AMERICAN MARKET SHARE IN 2023
  • FIGURE 23 INDIA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
  • FIGURE 24 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 25 AI IN REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 US MEDIAN HEALTHCARE DATA BREACH SIZE, 2009-2024
  • FIGURE 27 AI IN REMOTE PATIENT MONITORING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
  • FIGURE 28 AI IN REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 AI IN REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 AVERAGE SELLING PRICE FOR AI-BASED REMOTE PATIENT MONITORING DEVICES, BY TYPE (2023)
  • FIGURE 31 AI IN REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 34 PATENT PUBLICATION TRENDS IN AI IN REMOTE PATIENT MONITORING MARKET, 2015-2024
  • FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR AI-BASED REMOTE PATIENT MONITORING DEVICE PATENTS (JANUARY 2015-DECEMBER 2024)
  • FIGURE 36 TOP PATENT OWNERS/APPLICANTS IN AI IN REMOTE PATIENT MONITORING MARKET (JANUARY 2015-DECEMBER 2024)
  • FIGURE 37 AI IN REMOTE PATIENT MONITORING MARKET: FUNDING AND NUMBER OF DEALS, 2022-2024
  • FIGURE 38 US: PERCENTAGE OF NEW CANCER CASES (2024)
  • FIGURE 39 NORTH AMERICA: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 40 ASIA PACIFIC: AI IN REMOTE PATIENT MONITORING MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET, 2019-2023 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN REMOTE PATIENT MONITORING MARKET (2023)
  • FIGURE 43 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 44 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT
  • FIGURE 45 AI IN REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 48 AI IN REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 52 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 53 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT
  • FIGURE 54 RESMED, INC.: COMPANY SNAPSHOT
  • FIGURE 55 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 F. HOFFMANN-LA ROCHE LTD. (ROCHE DIAGNOSTICS): COMPANY SNAPSHOT
  • FIGURE 57 IRHYTHM INC.: COMPANY SNAPSHOT
  • FIGURE 58 MASIMO: COMPANY SNAPSHOT
  • FIGURE 59 DEXCOM, INC.: COMPANY SNAPSHOT